Mapping EQ-5D utility scores from the PedsQL™ generic core scales

PharmacoEconomics

Volumn 32, Issue 7, 2014, Pages 693-706

  Khan, Kamran A ^a   Petrou, Stavros ^a   Rivero Arias, Oliver ^b,c   Walters, Stephen J ^d   Boyle, Spencer E ^e  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Unidad Docente Multiprofesional de Atención Familiar y Comunitaria Oeste   (Spain)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e NORTHUMBRIA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE; ARTICLE; ATTITUDE TO HEALTH; CHILD; CROSS-SECTIONAL STUDY; EUROQOL 5D UTILITY SCORE; FEMALE; HEALTH CARE UTILIZATION; HEALTH STATUS; HIGH SCHOOL; HUMAN; MALE; MEASUREMENT ACCURACY; MEASUREMENT ERROR; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PEDIATRIC QUALITY OF LIFE INVENTORY GENERAL CORE SCALE; PEDIATRICS; PERFORMANCE MEASUREMENT SYSTEM; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; SEX RATIO; UNITED KINGDOM; VALIDATION STUDY; ALGORITHM; HEALTH STATUS INDICATOR; PSYCHOMETRY; QUESTIONNAIRE; REGRESSION ANALYSIS; THEORETICAL MODEL;

ADOLESCENT; ALGORITHMS; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MODELS, THEORETICAL; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 84903951853     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.1007/s40273-014-0153-y     Document Type: Article

References (45)

1. Dakin H, Petrou S, Haggard M, Benge S, Williamson I. Mapping analyses to estimate health utilities based on responses to the OM8-30 otitis media questionnaire. Qual Life Res. 2010;19(1):65-80. doi:10.1007/s11136-009-9558-z.
2. Culyer AJ. The dictionary of health economics. Cheltenham: Edward Elgar Publishing; 2005.
3. National Institute for Health and Care Excellence, (NICE). Guide to the methods of technology appraisal. National Institute for Health and Clinical Excellence (NICE); 2013.
4. Petrou S. Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ. 2003;12(8):697-702. (Pubitemid 37045311)
5. Tilford JM, Payakachat N, Kovacs E, Pyne JM, Brouwer W, Nick TG, et al. Preference-based health-related quality-of-life outcomes in children with autism spectrum disorders. Pharmacoeconomics. 2012;30(8):661-79.
6. Ungar WJ, Boydell K, Dell S, Feldman BM, Marshall D, Willan A, et al. A parent-child dyad approach to the assessment of health status and health-related quality of life in children with asthma. Pharmacoeconomics. 2012;30(8):697-712.
7. Griebsch I, Coast J, Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics. 2005;115(5):e600-14. (Pubitemid 43852793)
8. Eiser C, Morse R. Quality-of-life measures in chronic diseases of childhood. Health Technol Assess (Winchester, England). 2001;5(4):1.
9. Longworth L, Bojke L, Tosh J, Sculpher M. MRC-NICE scoping project: identifying the National Institute for Health and Clinical Excellence's methodological research priorities and an initial set of priorities. Centre for Health Economics, University of York Working Papers; 2009.
10. Stevens K. Valuation of the child health utility index 9D (CHU9D). 2010.
11. Longworth L, Rowen D. NICE DSU Technical Support Document 10: the use of mapping methods to estimate health state utility values; 2011.
12. Boyle SE, Jones GL, Walters SJ. Physical activity, quality of life, weight status and diet in adolescents. Qual Life Res. 2010;19(7):943-54.
13. The EQG. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208.
14. Räsänen P, Roine E, Sintonen H, Semberg-Konttinen V, Ryynänen OP, Roine R. Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review. Int J Technol Assess Health Care. 2006;22(02):235-41.
15. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095-108. (Pubitemid 127453463)
16. Szende A, Oppe M, Devlin N. EQ-5D value sets: inventory, comparative review and user guide, vol. 2. Berlin: Springer; 2006.
17. Eidt-Koch D, Mittendorf T, Greiner W. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. BMC Pediatr. 2009;9(1):55.
18. Wille N, Ravens-Sieberer U. Age-appropriateness of the EQ-5D adult and child-friendly version: testing the feasibility, reliability and validity in children and adolescents. In: 23rd Scientific Plenary Meeting of the EuroQol Group in Barcelona, Spain, September 14, vol 16. 2006. p. 217-9.
19. Varni JW, Burwinkle TM, Seid M. The PedsQL TM 4.0 as a school population health measure: feasibility, reliability, and validity. Qual Life Res. 2006;15(2):203-15. (Pubitemid 43230112)
20. McCullagh P, Nelder JA. Generalized linear models, vol. 37. London: Chapman & Hall/CRC; 1989.
21. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461-94. (Pubitemid 32515166)
22. Pearson E, Please N. Relation between the shape of population distribution and the robustness of four simple test statistics. Biometrika. 1975;62(2):223-41.
23. Pregibon D. Goodness of link tests for generalized linear models. Appl Stat. 1980;29:15-23.
24. Hosmer D. In: Lemeshow S (ed). Applied logistic regression. New York: Wiley; 1989. p. 8-20.
25. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. USA: Oxford University Press; 2007.
26. Powell JL. Least absolute deviations estimation for the censored regression model. J Econometr. 1984;25(3):303-25.
27. Chay KY, Powell JL. Semiparametric censored regression models. J Econ Perspect. 2001;15(4):29-42. (Pubitemid 33594772)
28. Tobin J. Estimation of relationships for limited dependent variables. Econometrica: J Econ Soc. 1958;26(1):24-36.
29. Brazier J, Yang Y, Tsuchiya A, Rowen D. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215-25. doi:10.1007/s10198-009-0168-z.
30. Pullenayegum EM, Tarride J-E, Xie F, Goeree R, Gerstein HC, O'Reilly D. Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Val Health. 2010;13(4):487-94.
31. Pullenayegum EM, Tarride J-E, Xie F, O'Reilly D. Calculating utility decrements associated with an adverse event marginal Tobit and CLAD coefficients should be used with caution. Med Decis Making. 2011;31(6):790-9.
32. Papke LE, Wooldridge JM. Econometric methods for fractional response variables with an application to 401 (K) plan participation rates. J Appl Econ. 1996;11(6):619-32. doi:10.2307/2285155.
33. Levy A, Christensen T, Johnson J. Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom. Health Qual Life Outcomes. 2008;6(1):73.
34. Dakin H, Gray A, Murray D. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score. Qual Life Res. 2012;1-12.
35. Gray AM, Rivero-Arias O, Clarke PM. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Making. 2006;26(1):18-29. doi:10.1177/0272989x05284108. (Pubitemid 43134124)
36. Le QAPP, Doctor JNP. Probabilistic mapping of descriptive health status responses onto health state utilities using Bayesian networks: an empirical analysis converting SF-12 into EQ-5D utility index in a National US sample. Med Care. 2011;49(5):451-60.
37. Kaambwa B, Billingham L, Bryan S. Mapping utility scores from the Barthel index. Eur J Health Econ. 1-11. doi:10.1007/s10198-011-0364-5.
38. Pinedo-Villanueva R, Turner D, Judge A, Raftery J, Arden N. Mapping the Oxford hip score onto the EQ-5D utility index. Qual Life Res. 1-11. doi:10.1007/s11136-012-0174-y.
39. Tsuchiya A, Brazier J, McColl E, Parkin D. Deriving preference-based single indices from non-preference based condition-specific instruments: converting AQLQ into EQ5D indices. 2002. http://eprints.whiterose.ac.uk/10952/
40. Cremeens J, Eiser C, Blades M. Factors influencing agreement between child self-report and parent proxy-reports on the Pediatric Quality of Life Inventory™ 4.0 (PedsQL™) Generic Core Scales. Health Qual Life Outcomes. 2006;4(1):58.
41. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727-36.
42. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multicountry study. Qual Life Res. 2012. 1-11. doi:10.1007/s11136-012-0322-4.
43. Pickard AS, De Leon MC, Kohlmann T, Cella D, Rosenbloom S. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care. 2007;45(3):259-3. doi:10.1097/01.mlr.0000254515.63841.81.
44. Kim S, Kim H, Lee S-I, Jo M-W. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Qual Life Res. 2012;21(6):1065-73. doi:10.1007/s11136-011-0018-1.
45. van Hout B, Janssen M, Feng Y-S, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Val Health. 2012;15(5):708-15.